| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Compound 1541A | CTRPv2 | pan-cancer | AAC | 0.18 | 6e-06 |
| mRNA | Methotrexate | GDSC1000 | pan-cancer | AAC | 0.13 | 2e-05 |
| mRNA | Ispinesib Mesylate | GDSC1000 | pan-cancer | AAC | 0.13 | 4e-05 |
| mRNA | 5-FU | CTRPv2 | pan-cancer | AAC | 0.14 | 6e-05 |
| mRNA | BRD-K84807411 | CTRPv2 | pan-cancer | AAC | 0.31 | 6e-05 |
| mRNA | BRD-K27224038 | CTRPv2 | pan-cancer | AAC | 0.31 | 8e-05 |
| mRNA | TL-1-85 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.0004 |
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0004 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0006 |
| mRNA | THZ-2-49 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.0009 |